ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
15.19
-0.77 (-4.82%)
At close: Aug 20, 2026, 4:00 PM EDT
15.19
0.00 (0.00%)
Pre-market: Aug 21, 2026, 8:41 AM EDT

ClearPoint Neuro Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
463407424167208265
Market Cap Growth
55.80%-4.08%153.78%-19.62%-21.59%-1.05%
Enterprise Value
498404406157179228
Last Close Price
15.1913.6815.386.798.4711.22

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.9611.0113.526.9810.1216.27
PB Ratio
43.0014.5216.717.905.645.44
P/TBV Ratio
-61.4216.718.305.805.47

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.7810.9412.956.558.7313.97

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
5.932.080.140.660.330.25
Net Debt / Equity Ratio
3.210.44-0.65-0.43-0.69-0.86
Net Debt / EBITDA Ratio
-1.23-0.570.880.421.593.17
Net Debt / FCF Ratio
-1.10-0.501.790.641.553.25
Asset Turnover
0.560.540.770.490.340.34
Inventory Turnover
2.091.881.661.200.991.27
Quick Ratio
3.754.942.463.655.9211.88
Current Ratio
4.755.913.224.877.5413.02
Return on Equity (ROE)
-226.52%-95.64%-81.24%-76.09%-38.37%-56.33%
Return on Assets (ROA)
-24.43%-20.41%-30.14%-28.59%-16.86%-17.58%
Return on Capital Employed (ROCE)
-38.30%-25.70%-68.40%-63.70%-33.50%-22.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.46%-6.28%-4.46%-13.21%-7.90%-5.43%
FCF Yield
-6.75%-6.01%-2.17%-8.64%-7.90%-4.85%
Buyback Yield / Dilution
-5.24%-4.76%-9.84%-1.75%-16.63%-30.82%
SEC Filings: 10-K · 10-Q